Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients.

Pinzani P, Salvianti F, Cascella R, Massi D, De Giorgi V, Pazzagli M, Orlando C.

Clin Chim Acta. 2010 Sep 6;411(17-18):1319-24. doi: 10.1016/j.cca.2010.05.024. Epub 2010 May 31.

PMID:
20576522
2.

Quantitative analysis of the BRAF V600E mutation in circulating tumor-derived DNA in melanoma patients using competitive allele-specific TaqMan PCR.

Ashida A, Sakaizawa K, Mikoshiba A, Uhara H, Okuyama R.

Int J Clin Oncol. 2016 Oct;21(5):981-988. Epub 2016 Apr 4.

PMID:
27041702
3.

Enhanced detection of BRAF-mutants by pre-PCR cleavage of wild-type sequences revealed circulating melanoma cells heterogeneity.

Fusi A, Berdel R, Havemann S, Nonnenmacher A, Keilholz U.

Eur J Cancer. 2011 Sep;47(13):1971-6. doi: 10.1016/j.ejca.2011.04.013. Epub 2011 May 12.

PMID:
21570823
4.

BRAFV600E detection in melanoma is highly improved by COLD-PCR.

Pinzani P, Santucci C, Mancini I, Simi L, Salvianti F, Pratesi N, Massi D, De Giorgi V, Pazzagli M, Orlando C.

Clin Chim Acta. 2011 May 12;412(11-12):901-5. doi: 10.1016/j.cca.2011.01.014. Epub 2011 Jan 22.

PMID:
21262211
5.

In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation.

Venesio T, Chiorino G, Balsamo A, Zaccagna A, Petti C, Scatolini M, Pisacane A, Sarotto I, Picciotto F, Risio M.

Mod Pathol. 2008 Jun;21(6):716-26. doi: 10.1038/modpathol.2008.41. Epub 2008 Apr 11.

6.

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma.

Pisareva E, Gutkina N, Kovalenko S, Kuehnapfel S, Hartmann A, Heinzerling L, Schneider-Stock R, Lyubchenko L, Shamanin VA.

Melanoma Res. 2014 Aug;24(4):322-31. doi: 10.1097/CMR.0000000000000090.

PMID:
24922189
7.

BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors.

Gonzalez-Cao M, Mayo-de-Las-Casas C, Molina-Vila MA, De Mattos-Arruda L, Muñoz-Couselo E, Manzano JL, Cortes J, Berros JP, Drozdowskyj A, Sanmamed M, Gonzalez A, Alvarez C, Viteri S, Karachaliou N, Martin Algarra S, Bertran-Alamillo J, Jordana-Ariza N, Rosell R.

Melanoma Res. 2015 Dec;25(6):486-95. doi: 10.1097/CMR.0000000000000187.

PMID:
26366702
8.

Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations.

Pinzani P, Salvianti F, Zaccara S, Massi D, De Giorgi V, Pazzagli M, Orlando C.

Clin Chim Acta. 2011 Nov 20;412(23-24):2141-5. doi: 10.1016/j.cca.2011.07.027. Epub 2011 Aug 3.

PMID:
21839068
9.

Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients.

Barbano R, Pasculli B, Coco M, Fontana A, Copetti M, Rendina M, Valori VM, Graziano P, Maiello E, Fazio VM, Parrella P.

Sci Rep. 2015 Dec 22;5:18592. doi: 10.1038/srep18592.

10.

Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.

Si L, Kong Y, Xu X, Flaherty KT, Sheng X, Cui C, Chi Z, Li S, Mao L, Guo J.

Eur J Cancer. 2012 Jan;48(1):94-100. doi: 10.1016/j.ejca.2011.06.056. Epub 2011 Jul 23.

PMID:
21788131
11.

Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors.

Sanmamed MF, Fernández-Landázuri S, Rodríguez C, Zárate R, Lozano MD, Zubiri L, Perez-Gracia JL, Martín-Algarra S, González A.

Clin Chem. 2015 Jan;61(1):297-304. doi: 10.1373/clinchem.2014.230235. Epub 2014 Nov 19.

12.

Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.

Lamy PJ, Castan F, Lozano N, Montélion C, Audran P, Bibeau F, Roques S, Montels F, Laberenne AC.

J Mol Diagn. 2015 Jul;17(4):366-73. doi: 10.1016/j.jmoldx.2015.02.004. Epub 2015 May 5.

PMID:
25952101
13.

Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.

Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, Kefford RF, von Deimling A, Scolyer RA.

Am J Surg Pathol. 2013 Jan;37(1):61-5. doi: 10.1097/PAS.0b013e31826485c0.

PMID:
23026937
14.

BRAF mutations in conjunctival melanoma.

Gear H, Williams H, Kemp EG, Roberts F.

Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2484-8.

PMID:
15277467
15.

Benign nodal nevi frequently harbor the activating V600E BRAF mutation.

Taube JM, Begum S, Shi C, Eshleman JR, Westra WH.

Am J Surg Pathol. 2009 Apr;33(4):568-71. doi: 10.1097/PAS.0b013e31818a64fb.

PMID:
19033861
16.

Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E.

Jarry A, Masson D, Cassagnau E, Parois S, Laboisse C, Denis MG.

Mol Cell Probes. 2004 Oct;18(5):349-52.

PMID:
15294323
17.

Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.

Bösmüller H, Fischer A, Pham DL, Fehm T, Capper D, von Deimling A, Bonzheim I, Staebler A, Fend F.

Hum Pathol. 2013 Mar;44(3):329-35. doi: 10.1016/j.humpath.2012.07.010. Epub 2012 Oct 22.

PMID:
23089489
18.

BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs.

Wong CW, Fan YS, Chan TL, Chan AS, Ho LC, Ma TK, Yuen ST, Leung SY; Cancer Genome Project.

J Clin Pathol. 2005 Jun;58(6):640-4. Review.

19.

Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma.

Feller JK, Yang S, Mahalingam M.

Mod Pathol. 2013 Mar;26(3):414-20. doi: 10.1038/modpathol.2012.168. Epub 2012 Oct 5.

20.

Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas.

Sviatoha V, Tani E, Ghaderi M, Kleina R, Skoog L.

Anticancer Res. 2010 Sep;30(9):3267-72.

PMID:
20944096

Supplemental Content

Support Center